The TMED10-mediated limitation of PKCδ availability results in the suppression of activation of PKCδ downstream effectors ROCK and JNK and, consequently, in the inhibition of stimuli-induced apoptosis in prostate cancer cells [60]. This evidence concerns the gene PRKCD and prostate carcinoma.